Literature DB >> 18721752

System-wide investigation of ErbB4 reveals 19 sites of Tyr phosphorylation that are unusually selective in their recruitment properties.

Alexis Kaushansky1, Andrew Gordus, Bogdan A Budnik, William S Lane, John Rush, Gavin MacBeath.   

Abstract

The first three members of the ErbB family of receptor tyrosine kinases activate a wide variety of signaling pathways and are frequently misregulated in cancer. Much less is known about ErbB4. Here we use tandem mass spectrometry to identify 19 sites of tyrosine phosphorylation on ErbB4, and protein microarrays to quantify biophysical interactions between these sites and virtually every SH2 and PTB domain encoded in the human genome. Our unbiased approach highlighted several previously unrecognized interactions and led to the finding that ErbB4 can recruit and activate STAT1. At a systems level, we found that ErbB4 is much more selective than the other ErbB receptors. This suggests that ErbB4 may enable ErbB2 and ErbB3 to signal independently of EGFR under normal conditions, and provides a possible explanation for the protective properties of ErbB4 in cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721752      PMCID: PMC2606095          DOI: 10.1016/j.chembiol.2008.07.006

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  47 in total

1.  Binding specificities and affinities of egf domains for ErbB receptors.

Authors:  J T Jones; R W Akita; M X Sliwkowski
Journal:  FEBS Lett       Date:  1999-03-26       Impact factor: 4.124

Review 2.  STATs as activators of apoptosis.

Authors:  C Schindler
Journal:  Trends Cell Biol       Date:  1998-03       Impact factor: 20.808

3.  A quantitative protein interaction network for the ErbB receptors using protein microarrays.

Authors:  Richard B Jones; Andrew Gordus; Jordan A Krall; Gavin MacBeath
Journal:  Nature       Date:  2005-11-06       Impact factor: 49.962

4.  Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast.

Authors:  Nicola L P Barnes; Sahar Khavari; Gary P Boland; Angela Cramer; W Fiona Knox; Nigel J Bundred
Journal:  Clin Cancer Res       Date:  2005-03-15       Impact factor: 12.531

5.  The involvement of ErbB4 with schizophrenia: association and expression studies.

Authors:  Gilad Silberberg; Ariel Darvasi; Ronit Pinkas-Kramarski; Ruth Navon
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

Review 6.  Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.

Authors:  A C Porter; R R Vaillancourt
Journal:  Oncogene       Date:  1998-09-17       Impact factor: 9.867

7.  Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.

Authors:  H H Kim; U Vijapurkar; N J Hellyer; D Bravo; J G Koland
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

8.  The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.

Authors:  Christopher C Williams; June G Allison; Gregory A Vidal; Matthew E Burow; Barbara S Beckman; Luis Marrero; Frank E Jones
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

9.  Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients.

Authors:  A A Memon; B S Sorensen; P Melgard; L Fokdal; T Thykjaer; E Nexo
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

10.  Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.

Authors:  Nadine Norton; Valentina Moskvina; Derek W Morris; Nicholas J Bray; Stanley Zammit; Nigel M Williams; Hywel J Williams; Anna C Preece; Sarah Dwyer; Jennifer C Wilkinson; Gillian Spurlock; George Kirov; Paul Buckland; John L Waddington; Michael Gill; Aiden P Corvin; Michael J Owen; Michael C O'Donovan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

View more
  40 in total

1.  Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase.

Authors:  Hao Zhang; Wei Shen; Don Rempel; John Monsey; Ilan Vidavsky; Michael L Gross; Ron Bose
Journal:  Mol Cell Proteomics       Date:  2011-03-21       Impact factor: 5.911

Review 2.  Identification of Posttranslational Modification-Dependent Protein Interactions Using Yeast Surface Displayed Human Proteome Libraries.

Authors:  Scott Bidlingmaier; Bin Liu
Journal:  Methods Mol Biol       Date:  2015

3.  Crosstalk and competition in signaling networks.

Authors:  Michael A Rowland; Walter Fontana; Eric J Deeds
Journal:  Biophys J       Date:  2012-12-05       Impact factor: 4.033

4.  Reversal of impaired hippocampal long-term potentiation and contextual fear memory deficits in Angelman syndrome model mice by ErbB inhibitors.

Authors:  Hanoch Kaphzan; Pepe Hernandez; Joo In Jung; Kiriana K Cowansage; Katrin Deinhardt; Moses V Chao; Ted Abel; Eric Klann
Journal:  Biol Psychiatry       Date:  2012-03-03       Impact factor: 13.382

5.  TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.

Authors:  Valda C Hilliard; Mark R Frey; Peter J Dempsey; Richard M Peek; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-26       Impact factor: 4.052

6.  Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo.

Authors:  Jessica K Bernard; Sean P McCann; Vrinda Bhardwaj; Mary K Washington; Mark R Frey
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

7.  ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.

Authors:  Christopher S Williams; Jessica K Bernard; Michelle Demory Beckler; Dana Almohazey; Mary Kay Washington; Jesse J Smith; Mark R Frey
Journal:  Carcinogenesis       Date:  2015-04-27       Impact factor: 4.944

8.  Tyrosine-phosphorylated caveolin-1 blocks bacterial uptake by inducing Vav2-RhoA-mediated cytoskeletal rearrangements.

Authors:  Jan Peter Boettcher; Marieluise Kirchner; Yuri Churin; Alexis Kaushansky; Malvika Pompaiah; Hans Thorn; Volker Brinkmann; Gavin Macbeath; Thomas F Meyer
Journal:  PLoS Biol       Date:  2010-08-24       Impact factor: 8.029

9.  ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells.

Authors:  Mark R Frey; Valda C Hilliard; Matthew T Mullane; D Brent Polk
Journal:  Lab Invest       Date:  2010-06-28       Impact factor: 5.662

10.  Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.

Authors:  Stephanie N Brosius; Amy N Turk; Stephanie J Byer; Nicole M Brossier; Latika Kohli; Amber Whitmire; Fady M Mikhail; Kevin A Roth; Steven L Carroll
Journal:  Acta Neuropathol       Date:  2014-04       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.